About the Management Team

Michael G. O'Rand


President & Chief Executive Officer

 Michael O’Rand, Ph.D., is a retired professor in the Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, School of Medicine. Dr. O’Rand is a reproductive biologist and has more than 35 years of experience in studying mechanisms underlying human fertilization. Dr. O’Rand established the in vitro fertilization laboratory in UNC School of Medicine’s North Carolina Memorial Hospital and the first “test tube” baby in North Carolina. He has 5 issued or pending patents and more than 90 peer-reviewed publications. Dr. O’Rand has an A.B. from the University of California at Berkeley, an M.S. from Oregon State University, Corvallis, Oregon and a Ph.D. in Biology from Temple University, Philadelphia, PA.

Jeffrey A. Handler


Chief Operations Officer

Jeffrey A. Handler, Ph.D., DABT, MBA, is a Board certified toxicologist with broad experience in many areas of pharmaceutical and medical device research and development in multiple therapeutic areas, including antibacterials, therapeutic and aesthetic dermatology, stroke, Alzheimer’s disease, diabetes, urinary incontinence and rheumatoid arthritis, obtained over more than 27 years in the pharmaceutical business. He has extensive leadership and management skills within pharmaceutical R&D ranging from drug discovery through development and support of commercialized products and a track record of successful collaboration with colleagues in both scientific and commercial business areas. Dr. Handler has a Ph.D. in Pharmacology from the University of North Carolina at Chapel Hill and an MBA from Villanova University, Villanova, PA.

Katherine G. Hamil

Director of Laboratory Operations

 Katherine Hamil is a molecular biologist and biochemist with more than 30 peer-reviewd publications involving small secreted proteins and host defense in the male reproductive tract. She has 30 years of laboratory and project management experience and extensive repertoire of laboratory techniques. She trained and collaborated with M.D. and PhD students from many parts of the world. She has an B.S. from the University of Michigan at Ann Arbor and M.S. in Biochemistry from the University of North Carolina at Chapel Hill.

The Scientific Advisory Board

Laneta Dorflinger, PhD

Distinguished Scientist and Director, Contraceptive Technology Innovation, FHI360, Durham, NC 27701 USA

Areas of expertise: Contraceptive technologies, HIV prevention research, Reproductive health, Hormonal contraception

Gregory S. Kopf, PhD

Director, Research & Development, Global Health, Population & Nutrition, Contraceptive Technology Innovation, FHI360, Durham, NC 27701 USA

Areas of expertise: Reproductive health, Industry experience in women’s health (Wyeth), Contraceptive technology, reproductive (sperm and testis) biology.

John K. Amory MD, MPH

Professor of Medicine, Section Head, General Internal Medicine
University of Washington, Seattle WA

Areas of expertise: Board certified in internal medicine, Men’s reproductive health, Clinical evaluation of male contraceptives, Reproductive biology